Viewing StudyNCT00046111



Ignite Creation Date: 2024-05-05 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00046111
Status: COMPLETED
Last Update Posted: 2017-05-30
First Post: 2002-09-19

Brief Title: A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Solid Tumor Cancer
Lung Cancer Small Cell
Keywords:
Name View
Topotecan View
oral View
Bioequivalence View
Hycamtin View